Skip to main content
OpenTrials

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Completed

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

NCT00866307

Conditions
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +21 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 28 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum Augsburg Augsburg, Germany
  • Klinikum Bayreuth Bayreuth, Germany
  • Haematologisch-Onkologische Schwerpunktpraxis - Weilheim Berlin, Germany
View all 78 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004031

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Oregon Health & Science University Portland, Oregon, United States
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 15 locations
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02228096

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Childrens Hospital Los Angeles SC Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Children's Healthcare of Atlanta SC-2 Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details

Related conditions